Hanne Damgaard Jensen
Chief Development Officer (CDO) at Curasight- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
French -
Topline Score
Bio
Prof. Lars J. Petersen, MD DMSc CBA
I have worked with Hanne in several companies, from consultancy, start-ups to medium size biotech. She is a dedicated pharmaceutical executive with strong compentences within leadership, clinical development, regulatory science, and business development.
Morten Sandlykke
I was in the same team as Hanne during my Executive MBA education. I was very impressed with Hanne’s extremely structured and energetic approach to all challenges and projects. She is very professional and efficient in reaching targets without losing track on details or empathy for her team members on the way. I would gladly give Hanne my best recommendations for any job or any project that needs a prompt successful outcome with no diversions.
Prof. Lars J. Petersen, MD DMSc CBA
I have worked with Hanne in several companies, from consultancy, start-ups to medium size biotech. She is a dedicated pharmaceutical executive with strong compentences within leadership, clinical development, regulatory science, and business development.
Morten Sandlykke
I was in the same team as Hanne during my Executive MBA education. I was very impressed with Hanne’s extremely structured and energetic approach to all challenges and projects. She is very professional and efficient in reaching targets without losing track on details or empathy for her team members on the way. I would gladly give Hanne my best recommendations for any job or any project that needs a prompt successful outcome with no diversions.
Prof. Lars J. Petersen, MD DMSc CBA
I have worked with Hanne in several companies, from consultancy, start-ups to medium size biotech. She is a dedicated pharmaceutical executive with strong compentences within leadership, clinical development, regulatory science, and business development.
Morten Sandlykke
I was in the same team as Hanne during my Executive MBA education. I was very impressed with Hanne’s extremely structured and energetic approach to all challenges and projects. She is very professional and efficient in reaching targets without losing track on details or empathy for her team members on the way. I would gladly give Hanne my best recommendations for any job or any project that needs a prompt successful outcome with no diversions.
Prof. Lars J. Petersen, MD DMSc CBA
I have worked with Hanne in several companies, from consultancy, start-ups to medium size biotech. She is a dedicated pharmaceutical executive with strong compentences within leadership, clinical development, regulatory science, and business development.
Morten Sandlykke
I was in the same team as Hanne during my Executive MBA education. I was very impressed with Hanne’s extremely structured and energetic approach to all challenges and projects. She is very professional and efficient in reaching targets without losing track on details or empathy for her team members on the way. I would gladly give Hanne my best recommendations for any job or any project that needs a prompt successful outcome with no diversions.
Experience
-
Curasight
-
Denmark
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Development Officer (CDO)
-
Jan 2022 - Present
-
-
-
ROS Therapeutics
-
Copenhagen Area, Denmark
-
CEO, Founder
-
Apr 2018 - Present
ROS Therapeutics is a clinical stage pharmaceutical company committed to optimize the treatment experience and address unmet needs of children with Juvenile Idiopathic Arthritis (JIA) and other autoimmune and chronic inflammatory conditions through an innovative proprietary best-in-class orally delivered methotrexate therapy ROS Therapeutics is a clinical stage pharmaceutical company committed to optimize the treatment experience and address unmet needs of children with Juvenile Idiopathic Arthritis (JIA) and other autoimmune and chronic inflammatory conditions through an innovative proprietary best-in-class orally delivered methotrexate therapy
-
-
-
AimVion A/S
-
Aarhus, Denmark
-
Chairman Of The Board
-
Nov 2019 - Apr 2022
-
-
-
-
Chief Executive Officer
-
Jan 2009 - Mar 2017
My accomplishments at Azanta from various positions include registration of Diaphin in Denmark, as well as maturing Azanta's birth pill Angusta from idea to registration in the Nordics. Based on Azanta's market driven orientation, we established compassionate use/name patient programs for Azanta's oncology product, Nimoral, as well as the birth pill, Angusta, to reach significant sales figures before official entrance to the market. My accomplishments at Azanta from various positions include registration of Diaphin in Denmark, as well as maturing Azanta's birth pill Angusta from idea to registration in the Nordics. Based on Azanta's market driven orientation, we established compassionate use/name patient programs for Azanta's oncology product, Nimoral, as well as the birth pill, Angusta, to reach significant sales figures before official entrance to the market.
-
-
-
-
Sr. Vice President
-
2007 - 2009
Responsibility for Product Development including Toxicology, Clinical Operations, Medical Affairs, Regulatory Affairs, QA and Project Management Responsibility for Product Development including Toxicology, Clinical Operations, Medical Affairs, Regulatory Affairs, QA and Project Management
-
-
-
Genmab
-
Denmark
-
Biotechnology Research
-
700 & Above Employee
-
Senior Vice president
-
Dec 1999 - Mar 2007
Responsibility for Drug Development Responsibility for Drug Development
-
-
-
Novo Nordisk
-
Denmark
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Regulatory Affairs Manager
-
1995 - 1999
IND and NDA filing - Regulatory Project Manager IND and NDA filing - Regulatory Project Manager
-
-
-
-
Sr. Reg. Aff. Administrator
-
1990 - 1994
-
-
Education
-
2005 - 2007
Copenhagen Business School
MBA, Business and Administration -
1984 - 1990
Danmarks Farmaceutiske Universitet
M.Sc.Pharm -
2020 - 2020
Copenhagen Business School
Board Certification - small to medium sized enterprises
Community
